Stocks & Investing
Mon, September 18, 2023
[ Mon, Sep 18th 2023
] - WOPRAI
Wed, March 10, 2021
[ Wed, Mar 10th 2021
] - WOPRAI
Mon, February 22, 2021
[ Mon, Feb 22nd 2021
] - WOPRAI
Thu, February 11, 2021
[ Thu, Feb 11th 2021
] - WOPRAI
Mon, January 11, 2021
[ Mon, Jan 11th 2021
] - WOPRAI
Fri, January 8, 2021
[ Fri, Jan 08th 2021
] - WOPRAI
Mon, December 14, 2020
[ Mon, Dec 14th 2020
] - WOPRAI
Fri, November 13, 2020
[ Fri, Nov 13th 2020
] - WOPRAI
Fri, November 6, 2020
[ Fri, Nov 06th 2020
] - WOPRAI
Thu, August 20, 2020
[ Thu, Aug 20th 2020
] - WOPRAI
Tue, August 11, 2020
[ Tue, Aug 11th 2020
] - WOPRAI
Thu, June 25, 2020
[ Thu, Jun 25th 2020
] - WOPRAI
Thu, May 7, 2020
[ Thu, May 07th 2020
] - WOPRAI
Mon, July 15, 2019
[ Mon, Jul 15th 2019
] - WOPRAI
Fri, May 17, 2019
[ Fri, May 17th 2019
] - WOPRAI
Thu, March 30, 2017
[ Thu, Mar 30th 2017
] - WOPRAI
[ Thu, Mar 30th 2017
] - WOPRAI
Thu, December 11, 2014
[ Thu, Dec 11th 2014
] - WOPRAI
Wed, June 11, 2014
[ Wed, Jun 11th 2014
] - WOPRAI
Wed, April 30, 2014
[ Wed, Apr 30th 2014
] - WOPRAI
Fri, February 1, 2013
[ Fri, Feb 01st 2013
] - WOPRAI
Thu, April 12, 2012
[ Thu, Apr 12th 2012
] - WOPRAI
Martin Auster Initiated (BMRN) at Strong Buy and Held Target at $120 on, Sep 18th, 2023
Martin Auster of UBS, Initiated "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy and Held Target at $120 on, Sep 18th, 2023.
Martin has made no other calls on BMRN in the last 4 months.
There are 14 other peers that have a rating on BMRN. Out of the 14 peers that are also analyzing BMRN, 5 agree with Martin's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Luca Issi of "RBC Capital" Reiterated at Hold and Held Target at $100 on, Wednesday, September 13th, 2023
- Andreas Argyrides of "Wedbush" Maintained at Hold with Decreased Target to $70 on, Tuesday, August 1st, 2023
- George Farmer of "Scotiabank" Initiated at Hold and Held Target at $95 on, Thursday, July 27th, 2023
- Whitney Ijem of "Canaccord Genuity" Maintained at Hold with Decreased Target to $104 on, Monday, July 3rd, 2023
- David Lebowitz of "Citigroup" Maintained at Hold with Decreased Target to $96 on, Friday, June 30th, 2023
These are the ratings of the 9 analyists that currently disagree with Martin
- Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy and Held Target at $140 on, Friday, September 15th, 2023
- Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $120 on, Thursday, September 14th, 2023
- Debjit Chattopadhyay of "Guggenheim" Reiterated at Strong Buy and Held Target at $110 on, Wednesday, September 13th, 2023
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $125 on, Tuesday, August 1st, 2023
- Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $108 on, Tuesday, August 1st, 2023
- Geoff Meacham of "B of A Securities" Maintained at Strong Buy with Decreased Target to $185 on, Friday, July 21st, 2023
- Kostas Biliouris of "BMO Capital" Upgraded from Hold to Buy and Held Target at $102 on, Wednesday, July 5th, 2023
- Joel Beatty of "Baird" Reiterated at Buy and Held Target at $127 on, Friday, June 30th, 2023
- Tiago Fauth of "Credit Suisse" Initiated at Buy and Held Target at $120 on, Wednesday, June 14th, 2023
